Doç. Dr. NEYRAN KERTMEN

Yayın Ağı

SCI, SSCI ve AHCI İndekslerine Giren Dergilerde Yayınlanan Makaleler

Hypo-fractionated Stereotactic Re-Irradiation Outcomes For Recurrent Glioblastoma

Yilmaz M. T., KAHVECİOĞLU A., Mohammadipur S., Zorlu F., Oge K., KERTMEN N., et al.

RADIOTHERAPY AND ONCOLOGY , 2024 (SCI-Expanded)

Hypofractionated stereotactic re-irradiation for progressive glioblastoma: twelve years’ experience of a single center

Yilmaz M. T., KAHVECİOĞLU A., YAZICI G., Mohammadipour S., KERTMEN N., Cifci G. C., et al.

Journal of Neuro-Oncology , cilt.167, sa.2, ss.295-303, 2024 (SCI-Expanded)

Acute heart failure following pazopanib treatment: a literature review featuring two case reports

KERTMEN N., KAVGACI G., YILDIRIM H. Ç., DİZDAR Ö.

Anti-Cancer Drugs , cilt.35, sa.3, ss.302-304, 2024 (SCI-Expanded)

Seven-Year Single-Center Experience of the Efficacy and Safety of Ferric Carboxymaltose in Cancer Patients with Iron-Deficiency Anemia

AKTAŞ B. Y., ATA E. B., ÇEŞMECİ E., ÇAKIR İ. Y., Coşkunpınar M., TAHILLIOĞLU Y., et al.

Current Oncology , cilt.30, sa.11, ss.9689-9700, 2023 (SCI-Expanded)

SMART syndrome: a case report

Bozkurt S., Toprak B., YILDIRIM H. Ç., PARLAK SAĞOL Ş., GÜVEN D. C., KERTMEN N., et al.

ACTA NEUROLOGICA BELGICA , cilt.123, sa.3, ss.1137-1140, 2023 (SCI-Expanded)

KELIM score predicts outcome in patients with platinum-resistant/refractory recurrent ovarian cancer

KUŞ F., Guven D. C., YILDIRIM H. Ç., Chalabiyev E., AKYILDIZ A., Tatar O. D., et al.

Biomarkers in Medicine , cilt.17, sa.7, ss.379-389, 2023 (SCI-Expanded)

Optimal adjuvant treatment strategies for TNBC patients with residual disease after neoadjuvant treatment

Guven D. C., YILDIRIM H. Ç., KUŞ F., Erul E., KERTMEN N., DİZDAR Ö., et al.

Expert Review of Anticancer Therapy , cilt.23, sa.10, ss.1049-1059, 2023 (SCI-Expanded)

Lesson learned from the pandemic: Isolation and hygiene measures for COVID-19 could reduce the nosocomial infection rates in oncology wards

GÜVEN D. C., EROĞLU İ., Ismayilov R., ULUSOYDAN E., AKTEPE O. H., TELLİ DİZMAN G., et al.

JOURNAL OF ONCOLOGY PHARMACY PRACTICE , cilt.28, sa.8, ss.1807-1811, 2022 (SCI-Expanded) Sürdürülebilir Kalkınma

Comparison of Clinical and Pathological Factors Affecting Early and Late Recurrences in Patients with Operable Breast Cancer

YEKEDÜZ E., DİZDAR Ö., KERTMEN N., AKSOY S.

JOURNAL OF CLINICAL MEDICINE , cilt.11, sa.9, 2022 (SCI-Expanded)

HER2-low breast cancer could be associated with an increased risk of brain metastasis

GÜVEN D. C., KAYA M. B., Fedai B., ÖZDEN M., YILDIRIM H. Ç., KÖSEMEHMETOĞLU K., et al.

INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY , cilt.27, sa.2, ss.332-339, 2022 (SCI-Expanded) Sürdürülebilir Kalkınma

The use of fulvestrant before chemotherapy improves survival in hormone-positive breast cancer: a real-life study

GÜVEN D. C., YILDIRIM H. Ç., ERUL E., ŞAHİN T. K., ÇAKIR İ. Y., AKTEPE O. H., et al.

TURKISH JOURNAL OF MEDICAL SCIENCES , cilt.52, sa.5, ss.1551-1558, 2022 (SCI-Expanded)

Adjuvant treatment with paclitaxel plus trastuzumab for node-negative breast cancer: real-life experience

Diker O., AKTAŞ B. Y., Ak R., KÖYLÜ B., BAŞ O., TABAN H., et al.

FUTURE ONCOLOGY , cilt.18, ss.323-331, 2022 (SCI-Expanded) Sürdürülebilir Kalkınma

The association of BMI and sarcopenia with survival in patients with glioblastoma multiforme

GÜVEN D. C., AKSUN M. S., ÇAKIR İ. Y., KILIÇKAP S., KERTMEN N.

FUTURE ONCOLOGY , cilt.17, ss.4405-4413, 2021 (SCI-Expanded) Sürdürülebilir Kalkınma

Newly diagnosed cancer and the COVID-19 pandemic: tumour stage migration and higher early mortality

GÜVEN D. C., ŞAHİN T. K., YILDIRIM H. Ç., ÇEŞMECİ E., Incesu F. G. G., TAHILLIOĞLU Y., et al.

BMJ SUPPORTIVE & PALLIATIVE CARE , 2021 (SCI-Expanded)

Sarcopenia and anthracycline cardiotoxicity in patients with cancer

BAŞ O., ERDEMİR A. G., ONUR M. R., ÖZER N., ŞENER Y. Z., AKSU S., et al.

BMJ SUPPORTIVE & PALLIATIVE CARE , 2021 (SCI-Expanded) Sürdürülebilir Kalkınma

Poorer baseline performance status is associated with increased thromboembolism risk in metastatic cancer patients treated with immunotherapy

GÜVEN D. C., AKSUN M. S., ŞAHİN T. K., AKTEPE O. H., YILDIRIM H. Ç., TABAN H., et al.

SUPPORTIVE CARE IN CANCER , cilt.29, sa.9, ss.5417-5423, 2021 (SCI-Expanded) Sürdürülebilir Kalkınma

Adjuvant treatment with paclitaxel plus trastuzumab for node negative human epidermal growth factor receptor 2-positive breast cancer: Real life experience

Diker O., AKTAŞ B. Y., Ak R., KÖYLÜ B., BAŞ O., Olgun P., et al.

CANCER RESEARCH , cilt.81, sa.4, 2021 (SCI-Expanded) Sürdürülebilir Kalkınma

Pembrolizumab- and/or pazopanib-induced remitting seronegative symmetrical synovitis with pitting edema in a patient with renal cell carcinoma

BAŞ O., Ozbek A., Guven D., Aktepe O., KILIÇ L., KERTMEN N., et al.

JOURNAL OF ONCOLOGY PHARMACY PRACTICE , cilt.26, sa.5, ss.1230-1233, 2020 (SCI-Expanded)

Depression and anxiety in oncology nurses.

Keskin O., Oktay E., Turan M., Kertmen N., Tanriverdi O., Imamoglu G. I., et al.

JOURNAL OF CLINICAL ONCOLOGY , cilt.36, sa.15, 2018 (SCI-Expanded)

Comparison of prognosis and clinical features between synchronous bilateral and unilateral breast cancers

Karakas Y., KERTMEN N., LAÇİN Ş., Aslan A., DEMİR M., ATEŞ Ö., et al.

JOURNAL OF BUON , cilt.22, sa.3, ss.623-627, 2017 (SCI-Expanded) Sürdürülebilir Kalkınma

Correlation of educational status and clinicopathological characteristics of breast cancer: a single center experience

Sarici F., BABACAN T., Buyukhatipoglu H., Balakan O., SEVER A. R., KERTMEN N., et al.

JOURNAL OF BUON , cilt.21, sa.4, ss.826-831, 2016 (SCI-Expanded)

Assessment of psychosocial factors and distress in women having adjuvant endocrine therapy for breast cancer: the relationship among emotional distress and patient and treatment-related factors

ATEŞ Ö., SOYLU C., BABACAN T., Sarici F., KERTMEN N., Allen D., et al.

SPRINGERPLUS , cilt.5, 2016 (SCI-Expanded) Sürdürülebilir Kalkınma

Efficacy and safety of eribulin monotherapy in patients with heavily pretreated metastatic breast cancer

ATEŞ Ö., BABACAN T., KERTMEN N., Sarici F., Cenoli A., AKIN S., et al.

JOURNAL OF BUON , cilt.21, sa.2, ss.375-381, 2016 (SCI-Expanded) Sürdürülebilir Kalkınma

Anthracyclin - Based Chemotherapy in Patients with Non-Hodgkin Lymphoma Aged Over 75

Sarici F., KERTMEN N., Aslan A. C., Tasdemir V., BABACAN T., KILIÇKAP S., et al.

UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI , cilt.26, sa.2, ss.89-95, 2016 (SCI-Expanded)

Efficacy of capecitabine monotherapy as the first-line treatment of metastatic HER2-negative breast cancer

BABACAN T., Efe O., Hasirci A. S., Demirci F., Buyukhatipoglu H., Balakan O., et al.

TUMORI J , cilt.101, sa.4, ss.418-423, 2015 (SCI-Expanded) Sürdürülebilir Kalkınma

The lymph node ratio as an independent prognostic factor for non-metastatic node-positive breast cancer recurrence and mortality

Solak M., Turkoz F. P., Keskin O., AKSOY S., BABACAN T., Sarici F., et al.

JOURNAL OF BUON , cilt.20, sa.3, ss.737-745, 2015 (SCI-Expanded) Sürdürülebilir Kalkınma

Chemotherapy might not be beneficial in lymph node-negative, hormone-positive, and HER2-negative breast cancer patients: a long-term retrospective analysis

BABACAN T., Buyukhatipoglu H., Balakan O., KERTMEN N., Suner A., Sarici F., et al.

JOURNAL OF BUON , cilt.20, sa.2, ss.479-486, 2015 (SCI-Expanded) Sürdürülebilir Kalkınma

Comparison of three different induction regimens for nasopharyngeal cancer

KERTMEN N., AKSOY S., CENGİZ M., YAZICI G., KESKİN O., Babacan T., et al.

Asian Pacific Journal of Cancer Prevention , cilt.16, sa.1, ss.59-63, 2015 (SCI-Expanded)

Acquired C1 esterase inhibitor deficiency in a marginal zone lymphoma patient treated with rituximab

ATEŞ Ö., Sunar V., BABACAN T., AKIN S., KERTMEN N., Altundag K.

JOURNAL OF BUON , cilt.20, sa.1, ss.349, 2015 (SCI-Expanded)

A systemic late recurrence after the first operation in a patient diagnosed with early-stage breast cancer: the latest recurrence in the literature

Keskin O. D., KERTMEN N., Karakas Y., BABACAN T., ARIK Z., Altundag K., et al.

JOURNAL OF BUON , cilt.20, sa.1, ss.348, 2015 (SCI-Expanded)

Which sequence best protects the heart against trastuzumab and anthracycline toxicity An electron microscopy study in rats

KERTMEN N., AKSOY S., ÜNER A., ÖZGÜR Ö., keskin o., babacan t., et al.

Anticancer Research , 2015 (SCI-Expanded)

The effect of renin-angiotensin-system inhibition on survival and recurrence of N3+breast cancer patients

BABACAN T., Balakan O., Kuzan T. Y., Sarici F., Koca E., KERTMEN N., et al.

JOURNAL OF BUON , cilt.20, sa.1, ss.50-56, 2015 (SCI-Expanded) Sürdürülebilir Kalkınma

Molecular subtypes in patients with inflammatory breast cancer; A single center experience

KERTMEN N., BABACAN T., Keskin O., Solak M., Sarici F., AKIN S., et al.

JOURNAL OF BUON , cilt.20, sa.1, ss.35-39, 2015 (SCI-Expanded) Sürdürülebilir Kalkınma

A retrospective analysis of adjuvant CAF, AC-T and TAC regimens in triple negative early stage breast cancer

Buyukhatipoglu H., BABACAN T., KERTMEN N., Balakan O., Suner A., ATEŞ Ö., et al.

JOURNAL OF BUON , cilt.20, sa.1, ss.22-27, 2015 (SCI-Expanded)

Association between common risk factors and molecular subtypes in breast cancer patients

Turkoz F. P., Solak M., Petekkaya I., Keskin O., KERTMEN N., Sarici F., et al.

BREAST , cilt.22, sa.3, ss.344-350, 2013 (SCI-Expanded)

Diğer Dergilerde Yayınlanan Makaleler

Low-grade glial tumors: The experience of an oncology hospital in Türkiye

CEYLAN S., KERTMEN N., YAZICI G., KARS A.

Acta Medica , cilt.54, sa.2, ss.151-156, 2023 (Hakemli Dergi)

Does Combined Fractionated Stereotactic Radiotherapy and Immunotherapy Change the Outcome of Recurrent High-Grade Gliomas?

Sari S. Y., AKTAŞ B. Y., KERTMEN N., ELMALI A., Kilickap S., Oguz K. K., et al.

CUREUS , cilt.13, sa.6, 2021 (ESCI)

which sequence best protects the heart against trastuzumab and anthracycline toxicity? An electron microscopy study in rats

KERTMEN N.

Hacettepe Journal of Biology and Chemistry , cilt.15, ss.1056-1058, 2015 (Scopus)

Hakemli Kongre / Sempozyum Bildiri Kitaplarında Yer Alan Yayınlar

Embedded outpatient palliative care service within the oncology clinic: Preliminary experience in Hacettepe Oncology Hospital

Guven D. C., AKTEPE O. H., Berk Z., Guner G., Taban H., AKTAŞ B. Y., et al.

44th Congress of the European-Society-for-Medical-Oncology (ESMO), Barcelona, İspanya, 27 Eylül - 01 Ekim 2019, cilt.30

Clinicopathologic features of BRCA mutated breast cancer patients: Hacettepe experience

AKSOY S., DEĞİRMENCİLER R. F., AKTAŞ B. Y., Guven D. C., AKTEPE O. H., Guner G., et al.

44th Congress of the European-Society-for-Medical-Oncology (ESMO), Barcelona, İspanya, 27 Eylül - 01 Ekim 2019, cilt.30 Sürdürülebilir Kalkınma

Depression and anxiety in oncology nurses.

KESKİN Ö., OKTAY E., TURAN M., KERTMEN N., TANRIVERDİ Ö., İMAMOĞLU İNANÇ G., et al.

2018 ASCO Annual Meeting, Amerika Birleşik Devletleri, 5 - 08 Haziran 2018, ss.18552

Onkoloji Hemşirelerinde depresyon ve anksiyete

KESKİN Ö., OKTAY E., TURAN M., KERTMEN N., TANRIVERDİ Ö., İMAMOĞLU G. İ., et al.

22.ULUSAL KANSER KONGRESİ, Türkiye, 19 - 23 Nisan 2017

TRASTUZUMAB KARDİYOTOKSİSİTESİNİ İMMUNGLOBULİN /- STEROİD UYGULAMASI ÖNLEYEBİLİR Mİ?, TAVŞAN MODELİ HAYVAN DENEYİ

KERTMEN N., AKSOY S., ERMİŞ D. Y., KESKİN Ö., SOLAK M., ARIK Z., et al.

22. UKK, Türkiye, 19 - 23 Nisan 2017

Intravenous ferric carboxymaltose treatment in cancer patients

ASLAN A., TAŞDEMİR V., KERTMEN N., DİZDAR Ö., AKSOY S.

2016 ASCO Annual Meeting, 29 Mayıs - 03 Haziran 2016 Sürdürülebilir Kalkınma

Clinicopathologic characteristics of patients with recurrent or metastatic synovial sarcoma

ATEŞ Ö., AKSOY S., YETER H. H., Akın S., KERTMEN N., DİZDAR Ö., et al.

2016 ASCO Annual Meeting, 29 Mayıs - 03 Haziran 2016

Kadri Altundag Taner Babacan Orhan Efe Ahmet S Hasırcı Fatih Demirci Hakan Buyukhatıpoglu Ozan Balakan Furkan Saim Sarıcı Neyran Kertmen Ece Esin Serkan Akin Ozturk Ates Sercan Aksoy Ali R Sever

ALTUNDAĞ M. K., Babacan T., EFE O., HASIRCI A. S., DEMİRCİ F., BUYUKHATİPOGLU H., et al.

2015 ASCO Annual Meeting, 29 Mayıs - 02 Haziran 2015

Metrikler

Yayın

Atıf (WoS)

164

H-İndeks (WoS)

Atıf (Scopus)

115

H-İndeks (Scopus)

Proje

Açık Erişim

BM Sürdürülebilir Kalkınma Amaçları

Yayınlar & Eserler